Health News

Magyar Telecom B.V., Parent Company of Invitel Rt., Reports Financial Results for the Six Months Ended 30 June 2005
    BUDAORS, Hungary, Aug. 11 -Magyar Telecom B.V., parent company of Invitel Rt. ("Invitel") today reported its financial results for the six months ended 30 June 2005.     Financial and Operational Highlights:    -- Total revenue in EUR terms for the six months ended 30 June 2005     ...

NorthWestern to Host Third Quarter 2007 Financial Results Conference Call
SIOUX FALLS, S.D., Oct. 22 NorthWestern Corporation d/b/a NorthWestern Energy (Nasdaq: NWEC) today announced that it will host an investor conference call on Friday, Nov. 2, 2007 at 11:00 a.m. Eastern Time (10:00 a.m. Central Time) to review its financial results for the quarter ended Sept. 30, 2007. The Company also plans to issue a news release detailing its third ...

Hit a Home Run With Your Guests at Your Upcoming Baseball Party
PURCHASE, N.Y., Oct. 22 // -- Strike an impression with your adult friends when you gather to watch this year's fall classic. Instead of serving the typical combination of hot dogs and beer, Pernod Ricard USA, a leading producer of spirits and wine brands in the United States, suggests some relevant and classic alternatives, depending on your team ...

YM Biosciences announces adoption of renewed Shareholders Rights Plan
MISSISSAUGA, ON, Oct. 22 /-/ - YM BioSciences Inc. (AMEX: YMI, TSX: YM, AIM: YMBA), an oncology company that identifies, develops and commercializes differentiated products for patients worldwide, today announced that its Board of Directors has adopted a renewed Shareholder Rights Plan Agreement. The Rights Plan is designed to encourage the fair treatment of ...

ASCO and ASH Release Updated Guideline on the Use of Chemotherapy-Related Anemia Treatments in Cancer Patients
WASHINGTON, Oct. 22 /-USNewswire/ -- Today, the American Society of Hematology (ASH) and the American Society of Clinical Oncology (ASCO) have released an updated joint guideline on the use of erythropoiesis-stimulating agents (ESAs), a class of drugs that stimulate the bone marrow to produce more red blood cells, to treat chemotherapy-related ...

Nastech to Release Third Quarter Financial Results and Host Webcast on Monday, October 29, 2007
BOTHELL, Wash., Oct. 22 Nastech Pharmaceutical Company Inc. (Nasdaq: NSTK) announced today that its third quarter financial results will be released on Monday, October 29, 2007. Management will host a conference call with investors and financial analysts to discuss these results and to provide an update of the Company's clinical pipeline at 4:30 p.m. Eastern Time ...

HealthShares(TM) Announces Changes to the HealthShares(TM) Diagnostics and Composite Indexes
NEW YORK, Oct. 22 // -- HealthShares(TM) Inc., an investment company with a series of 20 underlying fund portfolios, today announced it has been informed by Standard & Poor's, the calculating agent for the HealthShares(TM) Indexes, that effective at the opening of trading on Thursday October 25, 2007, Amag Pharmaceuticals (Nasdaq: AMAG) will replace Cytyc Corp. ...

Aidas Rh-Apo2L Clinical Testing Shows Preliminary Efficacy in Helping to Treat Lung Cancer, Stomach Cancer, Lymphoma, Pancreatic Cancer & Kidney Cancer
SANTA MONICA, Calif., Oct. 22 Aida Pharmaceuticals, Inc. (OTC Bulletin Board: AIDA) today announced an update on its testing of Rh-Apo2L, the next large-scale product to be launched by the Company into the China market. Aida previously announced that it had successfully passed its Phase I tests in July 2006, which consists of tests for safety, dosage and the potential ...

Dynavax Begins TOLAMBA(TM) Environmental Exposure Chamber Study
BERKELEY, Calif., Oct. 22 Dynavax Technologies Corporation (Nasdaq: DVAX) today reported that it had begun dosing of TOLAMBA(TM), its novel ragweed allergy therapy, to subjects as part of an environmental exposure chamber study that is expected to enroll a total of 300 subjects. Subjects are being screened based on a history of ragweed allergy and a positive skin ...

WallSt.net Updates Investment Community Through All-New Interview with HealthSport
NEW YORK, Oct. 22 // -- Dan Kelly, President of HealthSport, Inc. (OTC Bulletin Board: HSPO) (http://www.healthsportinc.com) updated the investment community in an all-new interview with http://www.wallst.net. Topics covered in the interview include an overview of the company and its growth strategy, recent press releases, market opportunity, and upcoming milestones ...

AcroMetrix Releases New OptiQuant(R) HIV-1 Quantification Panel
BENICIA, Calif., Oct. 22 // -- AcroMetrix, the leading provider of quality control standards for clinical diagnostic and blood testing laboratories, announced that they have enhanced their OptiQuant HIV-1 Quantification Panel to be the first to utilize an EDTA-based normal human plasma matrix. This product is for Research Use Only, not for use in diagnostic ...

HealthAware Introduces Its SleepAware Cardiovascular Disease Module
DENVER, Oct. 22 // -- HealthAware, a leading supplier of innovative services to healthcare providers, announced today the launch of SleepAware, the newest module in the Company's cardiovascular program. SleepAware is a ground-breaking system that identifies at-risk patients with obstructive sleep apnea (OSA).    The program is a further extension ...

Diplomat Specialty Pharmacy Hires Vice President of Managed Markets
SWARTZ CREEK, Mich., Oct. 22 // -- Diplomat Specialty Pharmacy today announced that Dr. Atheer A. Kaddis has joined the company's executive management team. Dr. Kaddis will serve as Vice President of Managed Markets for the company. He reports directly to Diplomat Specialty Pharmacy's President and CEO, Philip Hagerman.    "The addition of Atheer ...

SuperGen to Announce 2007 Third Quarter Financial Results October 29, 2007
DUBLIN, Calif., Oct. 22 SuperGen Inc. (Nasdaq: SUPG), a pharmaceutical company dedicated to the discovery, rapid development and commercialization of therapies for solid tumors and hematological malignancies, today announced that it will release its 2007 third quarter financial results on Monday, Oct. 29, 2007. SuperGen Management will provide details on the ...

Preliminary Results of Randomized Pilot Study Show Comparable Efficacy for OrbusNeichs Genous(TM) Bio-engineered R Stent(TM) and Boston Scientifics Taxus(R) Stent in Patients at High Risk of Restenosis
WASHINGTON, Oct. 22 // -- The preliminary results of the first- ever randomized study to compare OrbusNeich's pro-healing stent, the Genous Bio-engineered R stent, with Boston Scientific's Taxus drug-eluting stent in high risk of restenosis patients show comparable efficacy at 30-day and six- month follow-up, reported Robbert de Winter, M.D., Ph.D., principal ...

Boston Scientific PROMUS(TM) and TAXUS(R) Stents Continue Strong Performance in Safety and Efficacy Measures
NATICK, Mass., and WASHINGTON, Oct. 22 Boston Scientific Corporation (NYSE: BSX) today welcomed results from the SPIRIT III Clinical Trial, which continue to support the proven safety and efficacy of the market-leading TAXUS(R) Express2(TM) Paclitaxel-Eluting Coronary Stent System and add to the growing body of strong clinical evidence for the XIENCE(TM) V ...

Simcere Pharmaceutical Group to Announce Third Quarter 2007 Earnings on Monday, November 5, 2007
Since Daylight Savings Time (DST) will change to Eastern Standard Time (EST) effective November 4, please note that the time of the Simcere Q3 conference call will take place at 9 p.m. (Beijing/Hong Kong time) on November 5, 2007, while the time of the call in the U.S. remains unchanged     at 8 a.m. (EST) before the market ...

Free Womens Cancer Screening Program Announces New Name, Hotline
DENVER, Oct. 22 // -- In the spirit of Breast Cancer Awareness Month, Women's Wellness Connection at the Colorado Department of Public Health and Environment is making it easier for Colorado women to live healthy, cancer-free lives.    Today, Women's Wellness Connection, formerly Colorado Women's Cancer Control Initiative, announces its new name ...

Age Affects Motivation for Quitting Smoking
Younger Smokers Worry About Smoking Cost; Older Smokers Worry About Health     Effects     CHICAGO, Oct. 22 // -- A new study shows that obstacles to smoking cessation and motives for quitting smoking vary with age. The study presented at CHEST 2007, the 73rd annual international scientific assembly of ...

Carbon Monoxide Test Helps Doctors Determine Patients Smoking Status
Science Project Turned Medical Study Reveals New Use for Pulse Cooxitmetry     CHICAGO, Oct. 22 // -- Pulse cooximeters have long been used to identify and measure the levels of carbon monoxide (CO) in the blood of patients or firefighters. But new research, presented at CHEST 2007, the 73rd annual international scientific assembly of the American ...

New Study Shows Lower Costs, Increased Consumer Engagement in Account-Based Health Plans
    Cost of care more than four percent lower     BLOOMINGTON, Minn., Oct. 22 /-USNewswire/ --HealthPartners today released results of a study that provide new evidence that members who have health savings accounts and health reimbursement accounts have lower medical costs and are more engaged in seeking out more cost ...

San Francisco Bay Area Autism Speaks Chapter Endorses Blue Ribbon Commission on Autism Recommendations for Equitable Insurance Coverage for Children With Autism
180,000 Children with Autism in California Lack Proper Healthcare Coverage     SAN FRANCISCO, Oct. 22 /-USNewswire/ -- The San Francisco Bay Area Chapter of Autism Speaks today announced the organization's endorsement of the California Legislative Blue Ribbon Commission on Autism's recommendations to ensure appropriate and equitable health insurance ...

FDA Approves Genzymes Renvela(TM) for Dialysis Patients
CAMBRIDGE, Mass., Oct. 22 Genzyme Corp. (Nasdaq: GENZ) today announced that the U.S. Food and Drug Administration has granted marketing approval for Renvela(TM) (sevelamer carbonate) for the control of serum phosphorus in patients with chronic kidney disease on dialysis. Renvela is a next-generation version of Renagel(R) (sevelamer hydrochloride), the most-prescribed ...

American M.R.I.-DOL: Small Hospitals To Turn The Camera On Themselves In Unique National Contest
America Called Upon to Help One Deserving Facility Win Needed Medical     Equipment by Choosing Its Favorite 'Clinical Contender'     MALVERN, Pa., Oct. 22 // -- Television medical dramas such as ER and House bring home images of the clinical challenges in hospitals across the country to millions of Americans each week. ...

Abbotts m2000(TM) Molecular Diagnostic Instrument and RealTime HIV-1 Test Win Chicago Innovation Award
Abbott Innovations Honored for Third Time in Five Years     ABBOTT PARK, Ill., Oct. 22 Abbott (NYSE: ABT) has received a 2007 Chicago Innovation Award for its m2000(TM) molecular diagnostic instrument (http://www.abbott.com/global/url/content/en_US/60.15:15/feature/Feature_0021.htm ) and the Abbott RealTime HIV-1 viral load test, the most ...

lexdon


2001 - 2015 Lexdon Business Library
TrustBase Registration
Privacy Policy
eTrust Privacy Certified